Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
2.000
-0.030 (-1.48%)
At close: Nov 4, 2024, 4:00 PM
1.970
-0.030 (-1.50%)
Pre-market: Nov 5, 2024, 5:45 AM EST
Esperion Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 392 | 340 | 459 | 306 | 725 | 1,630 | |
| Market Cap Growth | 219.48% | -25.93% | 49.97% | -57.77% | -55.52% | 32.13% | |
| Enterprise Value | 472 | 757 | 815 | 726 | 687 | 1,515 | |
| Last Close Price | 2.00 | 2.99 | 6.23 | 5.00 | 26.00 | 59.63 | |
| PE Ratio | - | -1.47 | -1.77 | -0.54 | -4.98 | -16.63 | |
| PS Ratio | 1.05 | 2.92 | 6.08 | 3.90 | 3.19 | 10.98 | |
| PB Ratio | -1.22 | -0.75 | -1.42 | -1.55 | -7.54 | 81.68 | |
| P/FCF Ratio | -42.45 | -2.51 | -2.63 | -1.16 | -8.42 | -22.86 | |
| P/OCF Ratio | -43.10 | -2.51 | -2.63 | -1.16 | -8.51 | -23.17 | |
| EV/Sales Ratio | 1.70 | 6.50 | 10.79 | 9.26 | 3.02 | 10.21 | |
| EV/EBITDA Ratio | 94.65 | -4.87 | -4.55 | -3.41 | -5.68 | -16.33 | |
| EV/EBIT Ratio | 95.45 | -4.86 | -4.54 | -3.40 | -5.66 | -16.27 | |
| EV/FCF Ratio | -74.98 | -5.59 | -4.66 | -2.75 | -7.98 | -21.25 | |
| Debt / Equity Ratio | -0.78 | -1.19 | -1.56 | -2.63 | -3.77 | 6.72 | |
| Debt / FCF Ratio | -27.16 | -3.99 | -2.89 | -1.96 | -4.21 | -1.88 | |
| Asset Turnover | 0.95 | 0.51 | 0.24 | 0.21 | 0.80 | 0.83 | |
| Inventory Turnover | 1.66 | 2.57 | 4.19 | 4.76 | - | - | |
| Quick Ratio | 1.42 | 0.84 | 2.17 | 3.85 | 3.37 | 3.04 | |
| Current Ratio | 1.97 | 1.29 | 2.67 | 4.48 | 3.68 | 3.20 | |
| Return on Equity (ROE) | - | - | - | - | - | -196.16% | |
| Return on Assets (ROA) | 1.05% | -42.86% | -35.64% | -36.31% | -26.73% | -32.52% | |
| Return on Capital (ROIC) | 8.16% | -72.90% | -44.78% | -45.52% | -36.14% | -49.91% | |
| Earnings Yield | -25.10% | -61.54% | -50.90% | -87.91% | -19.81% | -5.96% | |
| FCF Yield | -2.52% | -39.85% | -38.08% | -86.18% | -11.87% | -4.38% | |
| Buyback Yield / Dilution | -76.93% | -55.26% | -129.76% | -5.20% | -1.42% | -1.26% | |
| Total Shareholder Return | -76.93% | -55.26% | -129.76% | -5.20% | -1.42% | -1.26% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.